Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis

被引：36
作者：
Lehman, TJA
Striegel, KH
Onel, KB
机构：
[1] Cornell Univ, Sanford Weill Med Ctr, Hosp Special Surg, Div Pediat Rheumatol, New York, NY 10021 USA
[2] Cornell Univ, Sanford Weill Med Ctr, Dept Pediat, New York, NY 10021 USA
来源：
JOURNAL OF PEDIATRICS | 2002年 / 140卷 / 01期
关键词：
D O I：
10.1067/mpd.2002.120835
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Systemic onset juvenile rheumatoid arthritis unresponsive to nonsteroidal anti-inflammatory drugs may be controlled with corticosteroids, but these drugs have significant side effects. We report 2 steroid-dependent children with systemic onset juvenile rheumatoid arthritis who did not respond to multiple nonsteroidal anti-inflammatory drugs, methotrexate, azathioprine, cyclosporine, and etanercept. Both children had significant improvement with thalidomide therapy.
引用
收藏
页码：125 / 127
页数：3
相关论文
共 21 条
[1]  
Corral LG, 1999, J IMMUNOL, V163, P380
[2]  
Date Y, 1999, ARTHRITIS RHEUM, V42, P2577, DOI 10.1002/1529-0131(199912)42:12<2577::AID-ANR10>3.0.CO
[3]  
2-O
[4]  
De Benedetti F, 1999, J RHEUMATOL, V26, P425
[5]  
De Benedetti F, 2000, J RHEUMATOL, V27, P2246
[6]   Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial [J].
Ehrenpreis, ED ;
Kane, SV ;
Cohen, LB ;
Cohen, RD ;
Hanauer, SB .
GASTROENTEROLOGY, 1999, 117 (06) :1271-1277
[7]   The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis [J].
Fishman, D ;
Faulds, G ;
Jeffery, R ;
Mohamed-Ali, V ;
Yudkin, JS ;
Humphries, S ;
Woo, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1369-1376
[8]   CLINICAL-EXPERIENCE WITH THALIDOMIDE IN THE MANAGEMENT OF SEVERE ORAL AND GENITAL ULCERATION IN CONDITIONS SUCH AS BEHCETS-DISEASE - USE OF NEUROPHYSIOLOGICAL STUDIES TO DETECT THALIDOMIDE NEUROPATHY [J].
GARDNERMEDWIN, JMM ;
SMITH, NJ ;
POWELL, RJ .
ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (12) :828-832
[9]  
GATTORNO M, 1995, CLIN EXP RHEUMATOL, V13, P409
[10]   Tumor necrosis factor-α increased production during thalidomide treatment in patients with tuberculosis and human immunodeficiency virus coinfection [J].
Gori, A ;
Rossi, MC ;
Trabattoni, D ;
Marchetti, G ;
Fusi, ML ;
Molteni, C ;
Clerici, M ;
Franzetti, F .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (02) :639-639
123